CODX - CIK 0001692415
Co-Diagnostics, Inc. (CODX) reported net income of -$46.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$46.90M | -24.6% |
| FY 2024 | -$37.64M | -6.5% |
| FY 2023 | -$35.33M | -148.2% |
| FY 2022 | -$14.24M | -138.8% |
| FY 2021 | $36.66M | -13.7% |
| FY 2020 | $42.48M | +785.6% |
| FY 2019 | -$6.20M | +1.2% |
| FY 2018 | -$6.27M | +9.9% |
| FY 2017 |
Co-Diagnostics, Inc. (CODX) reported net income of -$46.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, Co-Diagnostics, Inc.'s net income declined from -$1.93M to -$46.90M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$6.96M |
| -260.8% |
| FY 2016 | -$1.93M | - |